Hi ,
|
There's an iGEM team from Uganda that has a GoFundMe page to help them go to the iGEM jamboree, they surely appreciate your
contributions!
It's been a huge week in DNA reading this week, with the Illumina Genomics Forum in San Diego. There was a star-studded appearance from the likes of Barack Obama and Bill Gates. The big news out this week is the falling cost of reading a whole human genome. Illumina announced this new machine which will sequence genomes at just $200. If you love DNA, come hear more from Illumina CEO Francis deSouza (pictured
below) as he is going to be giving a keynote at SynBioBeta 2023.
|
 |
Genomatica (Geno) welcomed a global consumer products and chemical company, Kao Corporation, to its venture to scale and
commercialize plant-based alternatives to palm kernel oil, joining Unilever as a founding member. Kao's investment adds to Geno's previously announced $120M venture with Unilever and increases the production capability of the palm kernel oil alternative.
|
 |
Christophe Schilling, CEO of Genomatica.
Congratulations to Maria Soloveychik and the team at SyntheX, which announced a $550 million
research collaboration with Bristol Myers-Squibb to develop better cancer drugs with SyntheX’s drug discovery platforms.
In case you missed it, here are the latest speakers who will be at SynBioBeta 2023:
|
 |
Jennifer Holmgren, CEO of LanzaTech, views carbon not as a waste, but as a resource.
Friederike Grosse-Holz is a Director on the Blue Horizon Growth Investing team, and identifies investments in the technologies that will have a real impact on food industry sustainability.
Avencia Sanchez-Mejias, CEO of Integra Tx, is creating gene-writing tools to make advanced therapies safer and more effective.
- Patricia Bubner, CEO of Orbillion Bio, is working on building a future of food that is ethical and sustainable.
New sponsors include:
Ailurus, a company building the architecture and programming language to engineer
biology as we program a classical computer.
Orbillion, who crafts premium cultured meat from top-quality heritage breeds.
On-Chip, manufacturer of a microfluidic cell sorter (On-chip Sort) and other
microfluidic technologies.
Cemvita Factory, who uses synthetic biology to create nature-inspired
economical solutions to empower the energy transition.
Molecular Assemblies, who is developing a revolutionary, enzymatic DNA
synthesis technology capable of powering new products.
Are you joining them at SynBioBeta 2023? You can REGISTER HERE TODAY.
Congratulations to Stemloop on the launch of their new product at Chicago Water Week. I'm an advisor to the company and I couldn't be more thrilled to see cell-free synthetic biology for rapid detection of lead-in-water.
|
 |
Khalid Alam, CEO of Stemloop.
LanzaTech announced a $500 million
funding partnership with Brookfield Renewable, and its institutional partners, to co-develop and build new commercial-scale production plants that will employ LanzaTech’s Carbon Capture and Transformation technology, which transforms captured carbon into valuable raw material commodities. The company also announced a European base at the Biotech Campus Delft.
Ginkgo
Bioworks has announced the acquisition of two biotech companies, Altar, a French firm with a proprietary adaptive evolution platform, and Circularis, which has a proprietary circular RNA and promoter screening platform.
Agribusiness leader ADM and biotech company Spiber announced a new joint agreement to support the adoption of regenerative farming practices for Spiber’s Brewed Protein™.
In other news, The National Academies of Sciences, Engineering, and Medicine will appoint a committee of experts to organize and
convene a workshop on October 24-25 to explore domestic and international advancements in biomanufacturing.
What a week this was for the bioeconomy!
Regards,
John
---
John Cumbers
Founder, SynBioBeta
|
|
|
|
|
|
|
 |
bit.bio adds two new human cell products to accelerate drug discovery for neurodegenerative disease |
bit.bio’s latest cell products provide a scalable source of human cells and will enable scientists to study neurodegenerative diseases in a human context. (Press release)
|
Keep Reading
»
|
|
 |
BUCHA BIO accelerates manufacturing plans for biobased materials with $1.1M raise |
The company makes biobased materials using bacterial nanocellulose and other plant-based components that replace unsustainable conventional leathers and plastics. (Press release)
|
Keep Reading »
|
|
|
 |
Download the application note to learn how Inscripta’s Onyx® Digital Genome Engineering Platform can be used for rapid strain engineering to improve heterologous protein production.
|
Keep Reading
»
|
|
 |
Biologists use genetic circuits to program plant roots |
Using inserted genetic circuitry, synthetic biologists controlled the growth of plant roots for the first time. (Quanta Magazine)
|
Keep Reading »
|
|
|
|
|
Who's hiring?
|
- Scientist, Biology, Amyris, Emeryville, CA
- Product Manager, Molecular Biology, Genscript, Remote
- Staff Data Scientist, DNA Products, Twist Bioscience, US
- Associate Technical Director, Microbial Engineering, Ginkgo Bioworks, Boston, MA
- Research Associate - Mammalian Synthetic Biology, 64x Bio, San Francisco, CA
- Head of Functional Genomics, 64x Bio, San Francisco, CA
- Platform Program Manager, 64x Bio, San Francisco, CA
- Lab Support Associate, 64x Bio, San Francisco, CA
- Director of Operations, 64x Bio, San Francisco, CA
- Software Engineer, 64x Bio, San Francisco, CA
- Automation Engineer, 64x Bio, San Francisco, CA
- Director of Business Development, 64x Bio, San Francisco, CA
- Automation Research Associate, LanzaTech, Skokie, IL
- Senior Knowledge Analyst, Deep Tech, BCG, Remote, US or Europe based
- Senior Software Engineer/ Staff Software Engineer, Inscripta, Pleasanton, CA or Boulder, CO
- Senior Scientist/ Engineer, Inscripta, Pleasanton, CA
|
|
|
|
SynBioBeta, LLC
3559 Mount Diablo Boulevard #2, Lafayette, CA 94549
info@synbiobeta.com
If you no longer wish to receive our emails, you can unsubscribe here.
Modify Your Email Preferences
|
|
|
|
|
